» Articles » PMID: 38816637

Chemical Constituents and Pharmacological Properties of Frankincense: Implications for Anticancer Therapy

Overview
Date 2024 May 30
PMID 38816637
Authors
Affiliations
Soon will be listed here.
Abstract

The discovery of novel antitumor agents derived from natural plants is a principal objective of anticancer drug research. Frankincense, a widely recognized natural antitumor medicine, has undergone a systematic review encompassing its species, chemical constituents, and diverse pharmacological activities and mechanisms. The different species of frankincense include Boswellia serrata, Somali frankincense, Boswellia frereana, and Boswellia arabica. Various frankincense extracts and compounds exhibit antitumor, anti-inflammatory, and hepatoprotective properties and antioxidation, memory enhancement, and immunological regulation capabilities. They also have comprehensive effects on regulating flora. Frankincense and its principal chemical constituents have demonstrated promising chemoprophylactic and therapeutic abilities against tumors. This review provides a systematic summary of the mechanism of action underlying the antitumor effects of frankincense and its major constituents, thus laying the foundations for developing effective tumor-combating targets.

References
1.
Hamidpour R, Hamidpour S, Hamidpour M, Shahlari M . Frankincense ( rǔ xiāng; boswellia species): from the selection of traditional applications to the novel phytotherapy for the prevention and treatment of serious diseases. J Tradit Complement Med. 2014; 3(4):221-6. PMC: 3924999. DOI: 10.4103/2225-4110.119723. View

3.
Rumgay H, Arnold M, Ferlay J, Lesi O, Cabasag C, Vignat J . Global burden of primary liver cancer in 2020 and predictions to 2040. J Hepatol. 2022; 77(6):1598-1606. PMC: 9670241. DOI: 10.1016/j.jhep.2022.08.021. View

4.
Dai G, He L, Yan Q, Li Y, Huang Y, Li B . Case Report: Advanced pulmonary sarcomatoid carcinoma with adrenal gland metastasis after sintilimab combined with anlotinib treatment. Front Oncol. 2023; 13:1167516. PMC: 10348826. DOI: 10.3389/fonc.2023.1167516. View

5.
Motyka S, Jafernik K, Ekiert H, Sharifi-Rad J, Calina D, Al-Omari B . Podophyllotoxin and its derivatives: Potential anticancer agents of natural origin in cancer chemotherapy. Biomed Pharmacother. 2022; 158:114145. DOI: 10.1016/j.biopha.2022.114145. View

6.
Kaur H, Kaur K, Singh A, Bedi N, Singh B, Alturki M . Frankincense oil-loaded nanoemulsion formulation of paclitaxel and erucin: A synergistic combination for ameliorating drug resistance in breast cancer: and study. Front Pharmacol. 2022; 13:1020602. PMC: 9623270. DOI: 10.3389/fphar.2022.1020602. View